mosunetuzumab in the treatment of hcl: a case study
Published 3 months ago • 39 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:55
mosunetuzumab in untreated fl and mzl: a response-adapted trial
-
2:04
mosunetuzumab monotherapy in r/r fl
-
1:46
the value of mosunetuzumab in r/r fl
-
1:12
efficacy and safety of mosunetuzumab monotherapy for r/r follicular lymphoma
-
7:09
mosunetuzumab: next-generation antibody for follicular lymphoma
-
3:13
treatment using mosunetuzumab with or without obinutuzumab and polatuzumab vedotin in fl and mzl
-
2:16:50
pediatric hematology board review
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
2:16
epcoritamab versus mosunetuzumab in patients with r/r fl: findings of a maic
-
4:03
subcutaneous mosunetuzumab as first-line therapy in high tumor-burden follicular lymphoma
-
0:56
sunmo trial design: mosunetuzumab plus polatuzumab vedotin vs r-gemox in r/r nhl
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
3:54
a case study from the ecog-e1910 trial: early blinatumomab treatment in all
-
4:38
phase i study of neihulizumab in patients with sr-agvhd or tr-agvhd
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:19
what's on the horizon for the treatment of mpns?